October 17, 2018
InvaGen Pharmaceuticals Inc. is recalling 2880 bottles of amlodipine besylate USP 10-mg tablets (NDC 69097-128-15) over concerns about subpotency, according to the October 17, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The recall is for 1000-count bottles from lot GG80218 (Exp. 12/19). Cipla Ltd. manufactured the medication for Cipla USA. The affected bottles were distributed within the United States.
InvaGen Pharmaceuticals voluntarily initiated the recall October 3, 2018. The FDA designated the recall Class III October 11, 2018. The designation suggests use of the affected product is unlikely to cause adverse health consequences.
Amlodipine besylate is a prescription calcium channel blocker used to treat patients with high blood pressure and angina.
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here